We are pleased to announce a new partnership between the Advanced Therapies in Orthopaedics Foundation (ATiO) and the International Cartilage Regeneration & Joint Preservation Society (ICRS).
Through this collaboration, ATiO and ICRS aim to strengthen the exchange of scientific expertise and foster the development of innovative therapies in the field of orthopaedics — particularly in cartilage regeneration and joint preservation.
A Shared Vision for Musculoskeletal Health
Both organizations share a common mission: to accelerate the translation of cutting-edge science into tangible benefits for patients.
By combining ATiO’s global network of clinicians, researchers, investors, and industry leaders with the scientific and educational excellence of ICRS, this partnership will create new opportunities for collaboration and knowledge exchange across borders.
Key Areas of Collaboration
Under the Memorandum of Understanding, ATiO and ICRS will:
Facilitate mutual consultation and professional exchange on clinical studies and advanced therapy evaluations.
Cooperate in the development of standardized treatment guidelines and best practices for advanced therapies in cartilage and orthopaedic care.
Develop joint educational programs and training opportunities for both emerging and experienced clinicians.
Launch public awareness initiatives to promote understanding of advanced therapies and their potential to transform patient outcomes.
Encourage reciprocal participation in scientific meetings, including the ATiO Conference in Berlin and ICRS events worldwide.
A Step Toward a Global Network of Excellence
This partnership marks an important milestone in uniting two leading organizations dedicated to advancing orthopaedic innovation.
By building stronger bridges between academia, clinical practice, and industry, ATiO and ICRS are setting the stage for a new era of translational collaboration — one that aims to accelerate progress from bench to bedside.
“This understanding reflects a shared commitment to supporting progress in cartilage regeneration, joint preservation, and advanced therapies that can improve patient outcomes worldwide.”
— Prof. Tobias Winkler, Executive Board, ATiO Foundation
